Anheng Medical Partners with Almond Doctor to Expand Strategic Footprint of Capsule Gastroscope

Shanghai Ankon Medical Technologies Co., Ltd., which has stunned the industry with its independently innovative medical robot project, announced a formal strategic partnership with Xingren Doctor, further expanding the market reach of Ankon’s capsule gastroscopy robot.

This collaboration also expands Xingren Doctor’s mobile healthcare offerings with high-end medical products. By introducing a distinctive capsule endoscopy program, Xingren Doctor enables gastric health monitoring and gastric cancer screening for patients during follow-up care.

As the world’s first company to successfully develop and commercialize an “actively precision-controlled capsule endoscopy robot system for the gastrointestinal tract,” Anhan Medical holds a series of globally unique patents, including those for precise magnetic control and optoelectronic imaging. This technology has achieved revolutionary control and positioning capabilities for capsule endoscopes, thereby realizing the long-held health aspiration of undergoing gastroscopy without intubation, with its accuracy recognized by international authorities.

Now, by simply taking a sip of water and swallowing a capsule robot “Intelligently Made in China,” patients can undergo a comfortable and accurate gastroscopy that is painless, non-invasive, and requires no anesthesia.

Currently, the Anhan Capsule Gastroscopy Robot has been extensively deployed for clinical use in nearly 1,000 hospitals and health examination institutions across 29 provinces and municipalities in China, providing comfortable and accurate capsule gastroscopy services to diverse populations across different regions.

This collaboration with Xingren Doctor serves as a strong complement to its extensive offline hospital resources. Through mobile healthcare, it will directly reach 8 million patients, deeply instilling the concept of gastrointestinal examinations in public awareness and further promoting the widespread adoption of Anhan’s capsule gastroscopy across China.

Xingren Doctor was founded by a team with both medical and internet backgrounds. The founder and CEO, Dr. Martin, is the former Deputy President of United Family Hospital and General Manager of Siemens Healthineers. He previously served as a medical officer in the Royal Australian Navy, a general practitioner in Australian public hospitals, and participated in United Nations peacekeeping missions, boasting over 18 years of extensive experience in the healthcare sector.

Almond Doctor is a leading enterprise in China’s mobile healthcare sector and a career development partner for outstanding Chinese physicians. Almond Doctor has built an integrated online-and-offline practice platform that enables physicians to manage and serve patients. The platform boasts over 420,000 real-name verified physician users, covering more than 20,000 hospitals and medical institutions across China, and serving over 8 million highly targeted, high-quality patients. The emergence of Almond Doctor has redefined the way physicians practice medicine and optimized the patient care experience. Meanwhile, Almond Doctor collaborates with numerous leading companies extending along the medical value chain—including pharmaceutical and medical device suppliers, insurance providers, diagnostic and testing services, smart healthcare, and precision medicine—to jointly create a most valuable healthcare service ecosystem. The pronunciation of “Almond Doctor” in Chinese is similar to that of “Trusting Doctors,” which aptly embodies the platform’s vision of supporting physicians, serving patients, and improving doctor–patient relationships, thereby fostering greater trust and enabling diverse service models.

The Amy Doctor Open Platform is actively introducing outstanding domestic and international medical service providers and health service products to expand and strengthen the ecosystem of doctor-patient services. The establishment of a strategic partnership with Anhan Medical, featuring the introduction of capsule robots, reflects Amy’s commitment to the health management philosophy of “prevention first.” Leveraging advanced high-tech capsule gastroscopy robots, long-term monitoring of patients’ gastric health can be achieved, enabling the creation of comprehensive digestive tract health records. This facilitates early screening for gastric cancer, as well as the prediction, intervention, and timely treatment of gastric diseases. By combining the complementary strengths of Amy Doctor and Anhan Medical, both parties aim to maximize value and create a win-win scenario for doctors and patients alike.

China is a country with a high incidence of gastric cancer. In 2015, there were 680,000 new cases and 500,000 deaths, meaning that on average, someone dies from gastric cancer every minute. More than 90% of gastric cancer cases are diagnosed at an intermediate or advanced stage, imposing a heavy burden on families and society. A key characteristic of gastric cancer is its high cure rate when detected early; therefore, the fundamental approach to reducing the incidence of gastric cancer lies in early detection and treatment.

This collaboration introduces new methods and technologies for the examination, diagnosis, and treatment of gastrointestinal diseases. By leveraging the convenient platform of mobile health, it enables etiologic investigation, early screening, and follow-up treatment for gastrointestinal disorders, thereby establishing a comprehensive smart healthcare model. This initiative pioneers a new paradigm for gastric cancer prevention, early diagnosis, and early treatment tailored to the Chinese population.

In China, the diagnosis and treatment of gastrointestinal disorders face challenges such as a shortage of physicians and uneven distribution of medical resources. Patients often travel extensively in search of high-quality care, placing an excessive burden on tertiary hospitals. Through this collaborative model combining mobile healthcare with intelligent medical devices, Anhan has effectively expanded its service coverage, enabling more medical experts to serve the general public and facilitating early screening, diagnosis, and treatment of gastrointestinal diseases. This mobile healthcare approach truly optimizes the allocation of medical resources and enhances the efficiency of disease diagnosis, treatment, and prevention.

The “Healthy China 2030” Planning Outline states that by 2030, chronic disease health management should cover the entire population across the full life cycle, and the overall five-year cancer survival rate should increase by 15%. Leveraging their respective technological strengths, Anhan Medical and Xingren Doctor are committed to advancing the Healthy China initiative. By integrating mobile healthcare with high-end medical equipment, they are making the vision of comprehensive chronic disease management for digestive disorders a reality.